Quick Byte: PrEP advances


There are recent advances in preexposure prophylaxis, or PrEP, as a promising prevention option for HIV, according to a recent study.1

“Modeling studies suggest that pre-exposure prophylaxis has the potential to curtail the HIV epidemic when used as part of a combination public health prevention strategy. The estimated number needed to treat to prevent one new infection might be as low as 13 when pre-exposure prophylaxis is given to a group at high risk of HIV (for example, incidence of 9%).”


1. Desai M, Field N, Grant R, McCormack S. “Recent advances in pre-exposure prophylaxis for HIV.” BMJ. 2017;359:j5011.

Recommended Reading

Hospital-acquired conditions drop 8% since 2014, saving 8,000 lives and $3 billion
The Hospitalist
CDC warns of hepatitis A outbreaks in injection drug users
The Hospitalist
CMS sepsis measure a challenge to report
The Hospitalist
Diagnosing pulmonary tuberculosis in the hospital
The Hospitalist
Biomarker duo rapidly identifies serious bacterial infections
The Hospitalist
   Comments ()